secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K/A
Filed at:   2024-12-17T23:59:59+00:00
Accession:  0001645113-24-000036
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novocure details CEO Cordova compensation; Danziger transition terms set
------------------------------------------------------------------------

- Ashley Cordova named CEO effective Jan 1, 2025; base salary CHF 750K, target bonus 90% of base.
- Cordova severance: 100% base (non-CIC) or 200% base + 200% target bonus (CIC); equity fully vests on CIC termination.
- Asaf Danziger transitions to Senior Advisor through Dec 31, 2026; base salary $700K in 2025, then $120K.
- Danziger receives 400,000 RSUs vesting Dec 31, 2025 and 2026; forfeits certain PSUs upon CEO resignation.
- Both subject to 12-month non-compete, perpetual confidentiality, and non-disparagement covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511324000036/0001645113-24-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511324000036/nvcr-20240830.htm
  HTML page:      https://secwatch.observer/filing/0001645113-24-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer